0

    530207

    BRAWN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BRAWN BIOTECH LTD. Share Price Today

    Investment Returns

    Over 1 Month 10.34% Over 3 Months 2.63% Over 6 Months -7.76% Over 1 Year 15.11%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BRAWN BIOTECH LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 6.30
    • P/E Ratio (TTM) 6.69
    • Beta -0.09
    • Book Value / share 14.46
    • Return on equity -41.33%
    • EPS (TTM) 3.14
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.58
    info icon alternate text

    BRAWN BIOTECH LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.98
    Operating Expense 2.51
    Net Profit 0.58
    Net Profit Margin (%) 29.29
    Earnings Per Share (EPS) 1.95
    EBITDA -0.32
    Effective Tax Rate (%) 261.11
    Particulars DEC 2025 (Values in Cr)
    Revenue 4.31
    Operating Expense 4.35
    Net Profit 0.05
    Net Profit Margin (%) 1.16
    Earnings Per Share (EPS) 0.17
    EBITDA 0.08
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 4.89
    Operating Expense 4.91
    Net Profit 0.07
    Net Profit Margin (%) 1.43
    Earnings Per Share (EPS) 0.25
    EBITDA 0.10
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 5.80
    Operating Expense 5.65
    Net Profit 0.24
    Net Profit Margin (%) 4.13
    Earnings Per Share (EPS) 0.89
    EBITDA 0.27
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.26
    Operating Expense 2.84
    Net Profit -0.49
    Net Profit Margin (%) -21.68
    Earnings Per Share (EPS) -1.65
    EBITDA -0.45
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 16.98
    Operating Expense 17.43
    Net Profit 0.94
    Net Profit Margin (%) 5.53
    Earnings Per Share (EPS) 3.26
    EBITDA 0.12
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 13.47
    Operating Expense 15.35
    Net Profit -1.80
    Net Profit Margin (%) -13.36
    Earnings Per Share (EPS) -5.87
    EBITDA -1.69
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 16.49
    Operating Expense 18.12
    Net Profit -1.54
    Net Profit Margin (%) -9.33
    Earnings Per Share (EPS) -5.14
    EBITDA -1.44
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 22.23
    Operating Expense 22.65
    Net Profit -0.87
    Net Profit Margin (%) -3.91
    Earnings Per Share (EPS) -3.04
    EBITDA -0.29
    Effective Tax Rate (%) -112.19
    Particulars MAR 2022 (Values in Cr)
    Revenue 8.62
    Operating Expense 10.74
    Net Profit -1.64
    Net Profit Margin (%) -19.02
    Earnings Per Share (EPS) -5.25
    EBITDA -2.01
    Effective Tax Rate (%) 22.16
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 11.21
    ROE % -41.33
    ROCE % -18.71
    Total Debt to Total Equity 0.00
    EBITDA Margin -12.48
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 16.88
    ROE % -21.99
    ROCE % -20.47
    Total Debt to Total Equity 0.00
    EBITDA Margin -8.37
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 21.03
    ROE % -12.86
    ROCE % -5.74
    Total Debt to Total Equity 0.00
    EBITDA Margin -1.30
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 24.07
    ROE % -20.49
    ROCE % -24.95
    Total Debt to Total Equity 0.00
    EBITDA Margin -23.20
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 29.31
    ROE % -6.09
    ROCE % -3.49
    Total Debt to Total Equity 0.00
    EBITDA Margin -0.83
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.19
    Total Assets 20.48
    Total Liabilities 20.48
    Total Equity 3.36
    Share Outstanding 0
    Price to Book Ratio 1.45
    Return on Assets (%) -8.49
    Return on Capital (%) -51.75
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.39
    Total Assets 14.58
    Total Liabilities 14.58
    Total Equity 5.06
    Share Outstanding 0
    Price to Book Ratio 1.18
    Return on Assets (%) -8.54
    Return on Capital (%) -24.62
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.43
    Total Assets 14.53
    Total Liabilities 14.53
    Total Equity 6.30
    Share Outstanding 0
    Price to Book Ratio 0.79
    Return on Assets (%) -5.97
    Return on Capital (%) -13.76
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.22
    Total Assets 13.78
    Total Liabilities 13.78
    Total Equity 7.22
    Share Outstanding 0
    Price to Book Ratio 0.72
    Return on Assets (%) -11.92
    Return on Capital (%) -22.77
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.39
    Total Assets 13.87
    Total Liabilities 13.87
    Total Equity 8.79
    Share Outstanding 0
    Price to Book Ratio 0.75
    Return on Assets (%) -3.96
    Return on Capital (%) -6.26
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.79
    Cash from Operations 0.04
    Cash from Investing -0.24
    Cash from Financing 0.00
    Net change in Cash -0.19
    Free Cash Flow 0.28
    Particulars MAR 2024 (Values in Cr)
    Net Income -1.54
    Cash from Operations -0.02
    Cash from Investing -0.01
    Cash from Financing 0.00
    Net change in Cash -0.04
    Free Cash Flow -0.01
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.41
    Cash from Operations 0.30
    Cash from Investing -0.09
    Cash from Financing 0.00
    Net change in Cash 0.21
    Free Cash Flow 0.40
    Particulars MAR 2022 (Values in Cr)
    Net Income -2.11
    Cash from Operations 0.18
    Cash from Investing -0.29
    Cash from Financing -0.06
    Net change in Cash -0.17
    Free Cash Flow 0.48
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.35
    Cash from Operations 0.30
    Cash from Investing 0.00
    Cash from Financing -0.03
    Net change in Cash 0.00
    Free Cash Flow 0.30
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    BRAWN BIOTECH LTD. shareholding pattern

    Holding
    46.71%
    52.94%
    0.34%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    BRAWN BIOTECH LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    21.02 -4.45 redarrow
    red-green-graph indicator
    7 Bearish
    9 Bullish
    • 5 Days 21.20
    • 26 Days 20.70
    • 10 Days 0.00
    • 50 Days 20.70
    • 12 Days 20.90
    • 100 Days 20.60
    • 20 Days 20.80
    • 200 Days 20.40
    22.00 PIVOT
    First Support 22.00 First Resistance 22.00 Second Support 22.00 Second Resistance 22.00 Third Support 22.00 Third Resistance 22.00
    RSI 51.16 ADX 24.72 MACD 0.16 Williams % R -42.93 Commodity Channel Index (CCI) 46.93
    Date 2026-07-10 Week 1078.00 Same Day 1652.00 Month 728.00
    1 Year -0.10 3 Year 0.02
    Over 1 Month
    10.34% down
    Over 1 Year
    15.11% down
    Over 3 Months
    2.63% down
    Over 3 Years
    8.62% down
    Over 6 Months
    -7.76% down
    Over 5 Years
    0.84% down

    BRAWN BIOTECH LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
    14 Sep 2017 1.5 Final 16 Sep 2017 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Brawn Biotech Ltd?

    Answer Field

    Brawn Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.02 as on Jul 10 2026 03:15 PM.

    What is the Market Cap of Brawn Biotech Ltd Share?

    Answer Field

    The market cap of Brawn Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 6.30 as on Jul 10 2026 03:15 PM.

    What is the 52 Week High and Low of Brawn Biotech Ltd?

    Answer Field

    The 52 Week High and Low of Brawn Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 24.37 and ₹ 16.66.

    What is 1 year return for Brawn Biotech Ltd?

    Answer Field

    The 1 year returns on the stock has been 15.11%.

    What is the P/E Ratio of Brawn Biotech Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM the price-to-earnings (PE) ratio for Brawn Biotech Ltd share is 6.69.

    What is the PB ratio of Brawn Biotech Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM, the price-to-book (PB) ratio for Brawn Biotech Ltd share is 14.46.

    How to Buy Brawn Biotech Ltd Share?

    Answer Field

    You can trade in Brawn Biotech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Brawn Biotech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Brawn Biotech Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Brawn Biotech Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |